Cyhoeddiadau

Cyhoeddwyd

Adult survivors and their families: current needs and service responses

Krayer, A. M., Gwilym, H. M., Seddon, D., Krayer, A., Robinson, C. A., Gwilym, H., McKeown, G. & Hodrien, C., 1 Ion 2012, Unknown Publisher.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

Age and gender differences in grandchildren’s relations with maternal grandfathers and grandmothers.

Mann, R., Khan, H. T., Leeson, G. W. & Howse, K. (gol.), 1 Ion 2009, 2009 gol. Oxford Institute of Ageing Working Papers.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

Age and medical health needs for the elderly in Rural India

Wali, F., 5 Ebr 2023, 27 t.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

Agricultural policy and the environment in Syria: An examination of impacts and suggestions for policy reform

Edwards-Jones, G., 1 Ion 2001, 2001 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

Ahmadi Muslims in Pakistan: Assessing sufficiency of state protection

Wali, F., 16 Ion 2019, instructed on behalf of Katani and Co Solicitors.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Breastfeeding Five Year Action Plan

Brown, S., 3 Gorff 2019, Welsh Government. 24 t.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for STEMI.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for UA/NSTEMI.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency).

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Maraviroc (Celsentri) for treatment-experienced adults infected only with CCR5-tropic HIV-1.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Pegfilgrastim (Neulasta) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Raltegravir (Isentress) in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Rufinamide (Inovelon) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Stiripentol (Diacomit) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Teriparatide (Forsteo) for the treatment of osteoporosis in men at increased risk of fracture.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Trabectedin (Yondelis) for advanced soft tissue sarcoma.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Clofarabine (Evoltra)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Co-careldopa intestinal gel (Duodopa).

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Darunavir (Prezista)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Chronic, accelerated or blast phase CML.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Dexrazoxane (Savene)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Emtricitabine (Emtriva)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Idursulfase (Elaprase)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Parathyroid hormone (Preotact)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Appraisal Report – Tipranavir (Aptivus).

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All Wales Medicines Strategy Group Final Assessment Report – Agalsidase alfa (Replagal)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

All-optical wavelength conversion.

Tang, J., Fice, M., Khand, K. & Tang, J. M., 1 Ion 2001, 2001 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

Amenability of radial permeability of Sitka spruce (Picea sitchensis (Bong.) Carr.) as affected by aspects of cell ends in uniseriate ray parenchyma tissue.

Usta, I. & Hale, M. D., 1 Ion 2003, 2003 gol. Unknown.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

American Minimalism in Europe during the 1970s

ap Sion, P. E., 4 Rhag 2015, Unknown Publisher.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

An Evaluation of the Agencies Domestic Abuse Perpetrator Tasking (ADAPT) Programme in North Wales

Loftus, B. & Hodgkinson, C., 1 Meh 2023, 38 t.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

An Evaluation of the IPS Programme: I CAN Work

Williams, S., Prendergast, L., Roberts, S., Burton, C. & Hartfiel, N., 2021, Bangor University. 88 t.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

An analysis of the response to the Storm Emma-Holyhead Marina incident in March 2018: The release of marine litter after the storm and the resulting increased risk of spread of the colonial sea-squirt, Didemnum vexillum

Whitehead, J., Wyn, G., Griffith, K. & Moore, A., 2019, Natural Resources Wales. (NRW Evidence Report; Rhif 366)

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Cyhoeddwyd

An evaluation of the Women’s Turnaround Service in North Wales

Plows, A. J., Feilzer, M. Y. & Plows, A., 1 Meh 2012, Unknown Publisher.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Porth Ymchwil